✦ LIBER ✦

Long-term safety and tolerability of donepezil 23 mg in patients with moderate-to-severe Alzheimer's disease: An 18-month analysis

✍ Scribed by Farlow, Martin; Richardson, Sharon; Mackell, Joan; Sun, Yijun

Book ID: 122707461
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 50 KB
Volume: 7
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2011.05.2242

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety and tolerability of don

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease

✍ Pierre Tariot, Steven Salloway, Jane Yardley, Joan Mackell, Margaret Moline 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 197 KB

Efficacy and Safety of Donepezil 23 mg v

Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimers Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine

✍ Doody, Rachelle S.; Geldmacher, David S.; Farlow, Martin R.; Sun, Yijun; Moline, 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 458 KB

Tolerability of switching from donepezil

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease

✍ Gunhild Waldemar; Maritta Hyvärinen; Mette Krog Josiassen; Alex Kørner; Heikki L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving

Effects of donepezil 23 mg on Severe Imp

Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer’s disease: evaluating the impact of baseline severity

✍ Ferris, Steven; Cummings, Jeffrey; Christensen, Daniel; Doody, Rachelle; Farlow, 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 286 KB

Effect of donepezil 23 mg/day on languag

Effect of donepezil 23 mg/day on language function in patients with moderate-to-severe Alzheimer's disease (AD): Subgroup analysis of United States (U.S.)-based patients

✍ Ferris, Steven; Mackell, Joan; Bai, Zane; Sun, Yijun 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Donepezil is an `effective and realistic

Donepezil is an `effective and realistic symptomatic treatment' long-term in patients with mild-to-moderate Alzheimer's Disease (AD),

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB